Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

May 23, 2016May 23, 2016

Contour Systems, a Way for Diabetics to Monitor Their Glucose Levels, Soon Available in Europe

News

Ascensia Diabetes Care announced that its self-monitoring blood glucose systems for diabetes patients, CONTOUR NEXT ONE and CONTOUR PLUS ONE, have received the CE mark, meaning that the product has met the European Union’s safety, ... Read more

May 2, 2016May 2, 2016

Prolactin Serum Levels During Pregnancy Linked to Lower Risk of Postpartum Diabetes

insulin resistance, News, Type 2 Diabetes News

Researchers at the University of Toronto and the Mount Sinai Hospital in Toronto, Canada, analyzed pregnant women for glucose tolerance and levels of prolactin, among other factors, and found that high ... Read more

April 13, 2016April 13, 2016

Large-Scale Review Identifies Pathways Linking Diabetes and Alzheimer’s Disease

News

Melissa A. Schilling, a strategy and innovation expert at the NYU Stern School of Business, conducted a large-scale literature review of published studies on the association between diabetes and Alzheimer’s ... Read more

April 8, 2016April 8, 2016

Type 2 Diabetes Biomarkers Found in Early Study to Predict Disease Well Before Onset

News

Researchers at Lund University studied how age-related epigenetic changes might affect pancreatic cell functions and increase the risk of type 2 diabetes (T2D). Using a simple blood test, the team ... Read more

April 4, 2016April 4, 2016

TrialNet Researchers Develop Type 1 Diabetes Staging Classification

News

TrialNet, a worldwide leader in type 1 diabetes research, developed a new type 1 diabetes staging classification that identifies the disease’s progression. According to researchers, the classification system may help with ... Read more

April 1, 2016April 4, 2016

Type 2 Diabetes Patients May Benefit from Anti-Cancer Drug Gleevec, According to Researchers

News

In a new study, researchers from the Scripps Research Institute in the U.S., with colleagues from the Ulsan National Institute of Science and Technology (UNIST) in South Korea, Hyndai Pharm Co., and Seoul ... Read more

March 28, 2016March 28, 2016

Rare Genetic Form of Diabetes, MODY, Reacts Poorly with Type 2 Oral Drugs, Study Reports

News

In a new study, researchers at Washington University School of Medicine in St. Louis reported that treatment of a rare and often misdiagnosed form of diabetes, maturity-onset diabetes of the ... Read more

February 22, 2016February 22, 2016

Likelihood of Type 1 Diabetes Complications May Depend on Point Mutations in Vitamin B1 Transporters

News, Type 1 Diabetes News

Researchers investigated point mutations in two transporters of vitamin B1, a regulator of glucose metabolism, into the cells of type 1 diabetes patients and found that two specific mutations were ... Read more

February 17, 2016February 17, 2016

Study Shows Type 2 Diabetes Long-Term Drug Use Can Deteriorate Insulin-Producing Cells

News

In a new study, a team of researchers from the Karolinska Institutet in Sweden and the University of Miami in Florida analyzed the effects of treatment with analogues of the incretin ... Read more

January 15, 2016February 9, 2016

Type 2 Diabetes and Alzheimer’s Seen to Have Common Effect on Brain Enzymes

News

Scientists revealed a molecular link between the pathogenesis of type 2 diabetes and Alzheimer’s disease, shedding light on an association long thought to exist between the two diseases but poorly understood. In the ... Read more